Behavior therapy for children with tourette disorder

A randomized controlled trial

John Piacentini, Douglas W. Woods, Lawrence Scahill, Sabine Wilhelm, Alan L. Peterson, Susanna Chang, Golda S. Ginsburg, Thilo Deckersbach, James Dziura, Sue Levi-Pearl, John T. Walkup

Research output: Contribution to journalArticle

Abstract

Context: Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials. Objective: To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents. Design, Setting, and Participants: Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n=61) or a control treatment consisting of supportive therapy and education (n=65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment. Intervention: Comprehensive behavioral intervention. Main Outcome Measures: Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]). Results: Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95% confidence interval {CI}, 23.1-26.3] to 17.1 [95% CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95% CI, 23.2-26.0] to 21.1 [95% CI, 19.2-23.0]) (P

Original languageEnglish (US)
Pages (from-to)1929-1937
Number of pages9
JournalJournal of the American Medical Association
Volume303
Issue number19
DOIs
StatePublished - May 19 2010

Fingerprint

Tourette Syndrome
Behavior Therapy
Tics
Randomized Controlled Trials
Confidence Intervals
Therapeutics
Tic Disorders
Nervous System
Antipsychotic Agents
Outcome Assessment (Health Care)
Education

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., ... Walkup, J. T. (2010). Behavior therapy for children with tourette disorder: A randomized controlled trial. Journal of the American Medical Association, 303(19), 1929-1937. https://doi.org/10.1001/jama.2010.607

Behavior therapy for children with tourette disorder : A randomized controlled trial. / Piacentini, John; Woods, Douglas W.; Scahill, Lawrence; Wilhelm, Sabine; Peterson, Alan L.; Chang, Susanna; Ginsburg, Golda S.; Deckersbach, Thilo; Dziura, James; Levi-Pearl, Sue; Walkup, John T.

In: Journal of the American Medical Association, Vol. 303, No. 19, 19.05.2010, p. 1929-1937.

Research output: Contribution to journalArticle

Piacentini, J, Woods, DW, Scahill, L, Wilhelm, S, Peterson, AL, Chang, S, Ginsburg, GS, Deckersbach, T, Dziura, J, Levi-Pearl, S & Walkup, JT 2010, 'Behavior therapy for children with tourette disorder: A randomized controlled trial', Journal of the American Medical Association, vol. 303, no. 19, pp. 1929-1937. https://doi.org/10.1001/jama.2010.607
Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S et al. Behavior therapy for children with tourette disorder: A randomized controlled trial. Journal of the American Medical Association. 2010 May 19;303(19):1929-1937. https://doi.org/10.1001/jama.2010.607
Piacentini, John ; Woods, Douglas W. ; Scahill, Lawrence ; Wilhelm, Sabine ; Peterson, Alan L. ; Chang, Susanna ; Ginsburg, Golda S. ; Deckersbach, Thilo ; Dziura, James ; Levi-Pearl, Sue ; Walkup, John T. / Behavior therapy for children with tourette disorder : A randomized controlled trial. In: Journal of the American Medical Association. 2010 ; Vol. 303, No. 19. pp. 1929-1937.
@article{8bfcd6f1e8bb43d5bbd470e7562a0f79,
title = "Behavior therapy for children with tourette disorder: A randomized controlled trial",
abstract = "Context: Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials. Objective: To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents. Design, Setting, and Participants: Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n=61) or a control treatment consisting of supportive therapy and education (n=65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment. Intervention: Comprehensive behavioral intervention. Main Outcome Measures: Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]). Results: Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95{\%} confidence interval {CI}, 23.1-26.3] to 17.1 [95{\%} CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95{\%} CI, 23.2-26.0] to 21.1 [95{\%} CI, 19.2-23.0]) (P",
author = "John Piacentini and Woods, {Douglas W.} and Lawrence Scahill and Sabine Wilhelm and Peterson, {Alan L.} and Susanna Chang and Ginsburg, {Golda S.} and Thilo Deckersbach and James Dziura and Sue Levi-Pearl and Walkup, {John T.}",
year = "2010",
month = "5",
day = "19",
doi = "10.1001/jama.2010.607",
language = "English (US)",
volume = "303",
pages = "1929--1937",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "19",

}

TY - JOUR

T1 - Behavior therapy for children with tourette disorder

T2 - A randomized controlled trial

AU - Piacentini, John

AU - Woods, Douglas W.

AU - Scahill, Lawrence

AU - Wilhelm, Sabine

AU - Peterson, Alan L.

AU - Chang, Susanna

AU - Ginsburg, Golda S.

AU - Deckersbach, Thilo

AU - Dziura, James

AU - Levi-Pearl, Sue

AU - Walkup, John T.

PY - 2010/5/19

Y1 - 2010/5/19

N2 - Context: Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials. Objective: To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents. Design, Setting, and Participants: Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n=61) or a control treatment consisting of supportive therapy and education (n=65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment. Intervention: Comprehensive behavioral intervention. Main Outcome Measures: Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]). Results: Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95% confidence interval {CI}, 23.1-26.3] to 17.1 [95% CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95% CI, 23.2-26.0] to 21.1 [95% CI, 19.2-23.0]) (P

AB - Context: Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials. Objective: To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents. Design, Setting, and Participants: Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n=61) or a control treatment consisting of supportive therapy and education (n=65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment. Intervention: Comprehensive behavioral intervention. Main Outcome Measures: Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]). Results: Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95% confidence interval {CI}, 23.1-26.3] to 17.1 [95% CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95% CI, 23.2-26.0] to 21.1 [95% CI, 19.2-23.0]) (P

UR - http://www.scopus.com/inward/record.url?scp=77952389110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952389110&partnerID=8YFLogxK

U2 - 10.1001/jama.2010.607

DO - 10.1001/jama.2010.607

M3 - Article

VL - 303

SP - 1929

EP - 1937

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 19

ER -